221 related articles for article (PubMed ID: 29192863)
1. Precipitating hydrophobic injectable liquid embolization of intracranial vascular shunts: initial experience and technical note.
Varadharajan S; Ramalingaiah AH; Saini J; Gupta AK; Devi BI; Acharya UV
J Neurosurg; 2018 Nov; 129(5):1217-1222. PubMed ID: 29192863
[TBL] [Abstract][Full Text] [Related]
2. Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note.
Leyon JJ; Chavda S; Thomas A; Lamin S
J Neurointerv Surg; 2016 Jun; 8(6):596-602. PubMed ID: 25994938
[TBL] [Abstract][Full Text] [Related]
3. Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations.
Sirakov SS; Sirakov A; Minkin K; Hristov H; Ninov K; Penkov M; Karakostov V; Orlov K; Gorbatykh A; Kislitsin D; Raychev R
Interv Neuroradiol; 2019 Feb; 25(1):58-65. PubMed ID: 30223686
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.
Vollherbst DF; Otto R; von Deimling A; Pfaff J; Ulfert C; Kauczor HU; Bendszus M; Sommer CM; Möhlenbruch MA
J Neurointerv Surg; 2018 Mar; 10(3):268-274. PubMed ID: 28689184
[TBL] [Abstract][Full Text] [Related]
5. Transvenous embolization of brain arteriovenous malformations: a review of techniques, indications, and outcomes.
Chen CJ; Norat P; Ding D; Mendes GAC; Tvrdik P; Park MS; Kalani MY
Neurosurg Focus; 2018 Jul; 45(1):E13. PubMed ID: 29961383
[TBL] [Abstract][Full Text] [Related]
6. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas.
Vollherbst DF; Chapot R; Bendszus M; Möhlenbruch MA
Clin Neuroradiol; 2022 Mar; 32(1):25-38. PubMed ID: 34324005
[TBL] [Abstract][Full Text] [Related]
7. ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.
Rabinov JD; Yoo AJ; Ogilvy CS; Carter BS; Hirsch JA
J Neurointerv Surg; 2013 Jul; 5(4):306-10. PubMed ID: 22550096
[TBL] [Abstract][Full Text] [Related]
8. The dual microcatheter technique for transvenous embolization of dural arteriovenous fistulae.
Abecassis IJ; Nerva JD; Ghodke BV; Sekhar LN; Levitt MR; Kim LJ
J Neurointerv Surg; 2017 Jun; 9(6):578-582. PubMed ID: 27821474
[TBL] [Abstract][Full Text] [Related]
9. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA).
Duffner F; Ritz R; Bornemann A; Freudenstein D; Wiendl H; Siekmann R
Clin Neuropathol; 2002; 21(1):13-7. PubMed ID: 11846039
[TBL] [Abstract][Full Text] [Related]
10. Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations.
Koçer N; Hanımoğlu H; Batur Ş; Kandemirli SG; Kızılkılıç O; Sanus Z; Öz B; Işlak C; Kaynar MY
Diagn Interv Radiol; 2016; 22(2):184-9. PubMed ID: 26782157
[TBL] [Abstract][Full Text] [Related]
11. Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.
Vollherbst DF; Sommer CM; Ulfert C; Pfaff J; Bendszus M; Möhlenbruch MA
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1377-1382. PubMed ID: 28522669
[TBL] [Abstract][Full Text] [Related]
12. Staged transarterial endovascular embolization of a malignant dural arteriovenous fistula using Onyx and n-butyl cyanoacrylate.
Gesheva S; Couldwell WT; Mortimer V; Taussky P; Grandhi R
Neurosurg Focus; 2019 Apr; 46(Suppl_2):V1. PubMed ID: 30939434
[TBL] [Abstract][Full Text] [Related]
13. Novel use of precipitating hydrophobic injectable liquid (PHIL) in pre-operative angioembolisation of a large posterior auricular arteriovenous malformation.
Chu C; Tan THL; Ng KS; Tan CS; Lee TS; Yuen HW; Lee W; Huang XY
Am J Otolaryngol; 2023; 44(2):103786. PubMed ID: 36680841
[TBL] [Abstract][Full Text] [Related]
14. Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.
Lamin S; Chew HS; Chavda S; Thomas A; Piano M; Quilici L; Pero G; Holtmannspolter M; Cronqvist ME; Casasco A; Guimaraens L; Paul L; Gil Garcia A; Aleu A; Chapot R
AJNR Am J Neuroradiol; 2017 Jan; 38(1):127-131. PubMed ID: 27932510
[TBL] [Abstract][Full Text] [Related]
15. Ethmoidal dural arteriovenous fistula with unusual drainage route treated by transarterial embolization.
Inoue A; Tagawa M; Kumon Y; Watanabe H; Shoda D; Sugiu K; Ohnishi T
J Neurointerv Surg; 2015 Apr; 7(4):e15. PubMed ID: 24682847
[TBL] [Abstract][Full Text] [Related]
16. Open and endovascular treatment of spinal dural arteriovenous fistulas: a 10-year experience.
J Neurosurg Spine; 2017 Apr; 26(4):519-523. PubMed ID: 28106525
[TBL] [Abstract][Full Text] [Related]
17. Long-term angiographic results of endovascularly "cured" intracranial dural arteriovenous fistulas.
Ambekar S; Gaynor BG; Peterson EC; Elhammady MS
J Neurosurg; 2016 Apr; 124(4):1123-7. PubMed ID: 26406789
[TBL] [Abstract][Full Text] [Related]
18. Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas.
Gross BA; Albuquerque FC; Moon K; McDougall CG
J Neurosurg; 2017 Jun; 126(6):1884-1893. PubMed ID: 27588586
[TBL] [Abstract][Full Text] [Related]
19. Embolization of peripheral arteriovenous malformations and fistulas with precipitating hydrophobic injectable liquid (PHIL
Giurazza F; Corvino F; Silvestre M; Cangiano G; De Magistris G; Cavaglià E; Amodio F; Niola R
Radiol Med; 2021 Mar; 126(3):474-483. PubMed ID: 32889705
[TBL] [Abstract][Full Text] [Related]
20. Dural arteriovenous fistulas: a review of the literature and a presentation of a single institution's experience.
Ghobrial GM; Marchan E; Nair AK; Dumont AS; Tjoumakaris SI; Gonzalez LF; Rosenwasser RH; Jabbour P
World Neurosurg; 2013; 80(1-2):94-102. PubMed ID: 22381858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
